ARGENICA THERAPEUTICS LIMITED

ASX: AGN

Sector: Sector:Health Care
Industry group: Industry:Pharmaceuticals, Biotechnology & Life Sciences

Latest AGN ASX Announcements

29 Sept 2026 · 11:05 amDirector Interests
Change of Director's Interest Notice
29 Sept 202611:05 amChange of Director's Interest NoticeDirector Interests
23 Sept 2026 · 8:16 amMeetings & Governance
AGM Date & Closing Date for Director Nominations
23 Sept 20268:16 amAGM Date & Closing Date for Director NominationsMeetings & Governance
15 Sept 2026 · 8:12 amCompany Update
Concussion Data Selected for Neurotrauma Congress
15 Sept 20268:12 amConcussion Data Selected for Neurotrauma CongressCompany Update
26 Aug 2026 · 4:35 pmCompany Administration
Appendix 4G & Corporate Governance Statement
26 Aug 20264:35 pmAppendix 4G & Corporate Governance StatementCompany Administration
26 Aug 2026 · 4:29 pmFinancial Results
Appendix 4E & Annual Report to 30 June 2026
26 Aug 20264:29 pmAppendix 4E & Annual Report to 30 June 2026Financial Results
13 Aug 2026 · 5:32 pmSecurities Administration
Notification of cessation of securities - AGN
13 Aug 20265:32 pmNotification of cessation of securities - AGNSecurities Administration
27 July 2026 · 9:13 amPresentations
Investor Presentation - Techknow Conference
27 July 20269:13 amInvestor Presentation - Techknow ConferencePresentations
24 July 2026 · 9:18 amQuarterly Reports
Quarterly Activities/Appendix 4C Cash Flow Report
24 July 20269:18 amQuarterly Activities/Appendix 4C Cash Flow ReportQuarterly Reports
16 July 2026 · 8:27 amCompany Update
ARG007 Shows Significant Neuroprotection in Concussion Study
16 July 20268:27 amARG007 Shows Significant Neuroprotection in Concussion StudyCompany Update
11 June 2026 · 8:33 amPresentations
Investor Webinar
11 June 20268:33 amInvestor WebinarPresentations
11 June 2026 · 8:33 amPresentations
Investor Presentation
11 June 20268:33 amInvestor PresentationPresentations
11 June 2026 · 8:33 amCompany Update
ARG007 (Xaranetide) Completes All Three FDA Requested Assays
11 June 20268:33 amARG007 (Xaranetide) Completes All Three FDA Requested AssaysCompany Update
10 June 2026 · 8:19 amCompany Update
WHO Confirms Xaranetide as INN for ARG-007
10 June 20268:19 amWHO Confirms Xaranetide as INN for ARG-007Company Update
9 June 2026 · 2:13 pmSecurities Administration
Notification of cessation of securities - AGN
9 June 20262:13 pmNotification of cessation of securities - AGNSecurities Administration
26 May 2026 · 9:52 amSecurities Administration
Release of Securities from Voluntary Escrow
26 May 20269:52 amRelease of Securities from Voluntary EscrowSecurities Administration

View complete AGN announcement history →